IndiaTickerCertificate under SEBI (Depositories and Participants) Regulations, 2018 - Biofil Chemicals & Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Company dossier
Biofil Chemicals
NSE:BIOFILCHEM · ISIN INE829A01014
- Close
- ₹32.67 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Biofil Chemicals
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Trading Window - Biofil Chemicals & Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Copy of Newspaper Publication - Biofil Chemicals & Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday 30Th May, 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.BSE · exchange filing · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Audited Financial Result For The Financial Year Ended 31.03.2026BSE · financial results · pdf
Source filing Outcome of Board Meeting - Biofil Chemicals & Pharmaceuticals LimitedNSE · financial results · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Board Meeting Intimation for Meeting Of Board Of The Directors (Serial No.01/2026-27) Of The Company Scheduled To Be Held On Saturday, 30Th May, 2026.BSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Biofil Chemicals & Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015-Intimation To The Shareholders Holding Shares In Physical Mode For Mandatory Furnishing Of PAN, KYC Details, Bank Account Details, Nomination And Other Details.BSE · exchange filing · pdf
Source filing Updates - Biofil Chemicals & Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Biofil Chemicals & Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Intimation Regarding SEBI Circular Dated January 30, 2026 - Ease Of Doing Investment - Special Window For Transfer And Dematerialisation Of Physical SecuritiesBSE · exchange filing · pdf
Source filing Updates - Biofil Chemicals & Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Biofil Chemicals & Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Trading Window - Biofil Chemicals & Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Copy of Newspaper Publication - Biofil Chemicals & Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Un-Audited Financial Results Of The Company For The Quarter And Nine Month Ended On 31St December, 2025BSE · financial results · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 13Th February, 2026BSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Biofil Chemicals & Pharmaceuticals LimitedNSE · financial results · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Board Meeting Intimation for Meeting Of Board Of The Directors (Serial No. 07/2025-26) Of The Company Scheduled To Be Held On Friday, 13Th February 2026 .BSE · exchange filing · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Clarification On Price MovementBSE · exchange filing · pdf
Source filing Price movement - Biofil Chemicals & Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Biofil Chemicals & Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Trading Window - Biofil Chemicals & Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Receipt Of Fine From BSE Limited.BSE · exchange filing · pdf
Source filing Action(s) taken or orders passed - Biofil Chemicals & Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Action(s) taken or orders passed - Biofil Chemicals & Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing